Daniel DeAngelo
Has grant
Chief of the Division of Leukemia
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Daniel DeAngelo is the Chief of the Division of Leukemia at Dana-Farber Cancer Institute in the United States. His research focuses on various aspects of leukemia treatment, including acute lymphoblastic leukemia, myeloproliferative neoplasms, and acute myeloid leukemia. Dr. DeAngelo has published extensively on topics such as measurable residual disease, cardiovascular risk factors in hematological malignancies, and the clinical application of novel therapies.
Recent Grants
Grant: Close
P50 SPORE in Myeloid Malignancies
Open Date: 2017-01-01
Close Date: 2022-01-01
Grant: Close
Development of Novel Therapeutic Strategies in Human Leukemias: Core D Clinical Research Support Core
Open Date: 2014-01-01
Close Date: 2025-01-01
Grant: Close
Emerging Targets in Lymphoid Malignancies: Core D Leukemia Translational Therapeutics
Open Date: 2012-01-01
Close Date:
Articles (13)
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Collaborators (8)
Marlise Luskin
Dana-Farber Cancer Institute
Elisabetta Abruzzese
UNIVERSITY TOR VERGATA
Coleman Lindsley
Assistant Professor
Harvard Medical School
Evan Chen
Dana-Farber Cancer Institute
Anna Marneth
Assistant Professor
Radboudumc
Jason Gotlib
-
Andrew Lane
Dana-Farber Cancer Institute
Jorge Cortes
Augusta University
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.